Exact Mass: 273.1536

Exact Mass Matches: 273.1536

Found 465 metabolites which its exact mass value is equals to given mass value 273.1536, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

α- Erythroidine

α-Erythroidine

C16H19NO3 (273.1365)


   

beta-Erythroidine

β-Erythroidine

C16H19NO3 (273.1365)


An organic heterotetracyclic indole alkaloid isolated from the seeds and other parts of Erythrina species. It differs from the alpha isomer in having the double bond of the dihydropyranone ring located beta,gamma- to the lactone carbonyl group instead of alpha,beta-.

   
   

8-Allyl-2-phenyl-8H-1,3a,8-triaza-cyclopenta[a]indene

8-Allyl-2-phenyl-8H-1,3a,8-triaza-cyclopenta[a]indene

C18H15N3 (273.1266)


   

Norgalantamine

(-)-N-Demethylgalanthamine

C16H19NO3 (273.1365)


N-Desmethyl Galanthamine is a metabolite of Galanthamine. Galanthamine is a potent acetylcholinesterase (AChE) inhibitor with an IC50 of 500 nM[1][2].

   

Normaritidine

(-)-8-Demethylmaritidine

C16H19NO3 (273.1365)


   

Sanguinine

(1S,12S,14R)-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraene-9,14-diol

C16H19NO3 (273.1365)


Sanguinine is a benzazepine. Sanguinine is a natural product found in Lycoris sanguinea, Lycoris squamigera, and other organisms with data available. O-Desmethyl Galanthamine (Sanguinine) is galanthamine-type alkaloid. O-Desmethyl Galanthamine is an acetylcholinesterase (AChE) inhibitor, with an IC50 1.83 μM[1].

   

N-Desmethylzolmitriptan

N-Desmethyl Zolmitriptan

C15H19N3O2 (273.1477)


   

(2R,3R)-3-Methylglutamyl-5-semialdehyde-N6-lysine

(2R,3R)-3-Methylglutamyl-5-semialdehyde-N6-lysine

C12H23N3O4 (273.1688)


   

Tabtoxin biosynthesis intermediate 6

C20916; Tabtoxin biosynthesis intermediate 6

C11H19N3O5 (273.1325)


   
   

4-O-Methylnorbelladine

5-[[2-(4-hydroxyphenyl)ethylamino]methyl]-2-methoxy-phenol

C16H19NO3 (273.1365)


A phenethylamine alkaloid that is norbelladine in which the phenolic hydrogen at position 4 has been replaced by a methyl group.

   

(E,E)-Piperlonguminine

(Z,2E,4E)-5-(2H-1,3-benzodioxol-5-yl)-N-(2-methylpropyl)penta-2,4-dienimidic acid

C16H19NO3 (273.1365)


(E,E)-Piperlonguminine is a member of benzodioxoles. Piperlonguminine is a natural product found in Piper amalago, Piper retrofractum, and other organisms with data available. (E,E)-Piperlonguminine is found in herbs and spices. (E,E)-Piperlonguminine is an alkaloid from Piper longum (long pepper) and other Piper specie Alkaloid from Piper longum (long pepper) and other Piper subspecies (E,E)-Piperlonguminine is found in herbs and spices. Piperlonguminine is an alkaloid amide isolated from the Piper species. Piperlonguminine shows various biological properties, including anti-inflammatory, antitumor, neuroprotective, anti-platelet, anti-melanogenic, antifungal and antibacterial activities[1][2][3][4]. Piperlonguminine is an alkaloid amide isolated from the Piper species. Piperlonguminine shows various biological properties, including anti-inflammatory, antitumor, neuroprotective, anti-platelet, anti-melanogenic, antifungal and antibacterial activities[1][2][3][4].

   

(2E)-Piperamide-C5:1

(2E)-5-(2H-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)pent-2-en-1-one

C16H19NO3 (273.1365)


(2E)-Piperamide-C5:1 is found in herbs and spices. (2E)-Piperamide-C5:1 is a constituent of pepper fruits (Piper nigrum, Piperaceae). Constituent of pepper fruits (Piper nigrum, Piperaceae). (2E)-Piperamide-C5:1 is found in herbs and spices and pepper (spice).

   

Valylarginine

(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C11H23N5O3 (273.1801)


Valylarginine is a dipeptide composed of valine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Arginylvaline

(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C11H23N5O3 (273.1801)


Arginylvaline is a dipeptide composed of arginine and valine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Glutaconylcarnitine

(3S)-3-{[(2E)-4-carboxybut-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate

C12H19NO6 (273.1212)


Glutaconylcarnitine is an acylcarnitine. More specifically, it is an glutaconic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Glutaconylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine glutaconylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. A human metabolite taken as a putative food compound of mammalian origin [HMDB]

   

Heptanoylcarnitine

3-(heptanoyloxy)-4-(trimethylazaniumyl)butanoate

C14H27NO4 (273.194)


Heptanoylcarnitine is an acylcarnitine. More specifically, it is an heptanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Heptanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine heptanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. A human metabolite taken as a putative food compound of mammalian origin [HMDB]

   

Linalyl anthranilate

Anthranilic acid, 1, 5-dimethyl-1-vinyl-4-hexenyl ester

C17H23NO2 (273.1729)


Linalyl anthranilate is used in food flavourin It is used in food flavouring.

   

alpha-Terpinyl anthranilate

2-(4-Methylcyclohex-3-en-1-yl)propan-2-yl 2-aminobenzoic acid

C17H23NO2 (273.1729)


alpha-Terpinyl anthranilate is a flavouring ingredient with a complex fruity odour and bitter taste. Flavouring ingredient with a complex fruity odour and bitter taste

   

N-Despropyl-rotigotine

6-{[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol

C16H19NOS (273.1187)


N-Despropyl-rotigotine is a metabolite of rotigotine. Rotigotine (Neupro) is a non-ergoline dopamine agonist indicated for the treatment of Parkinsons disease (PD) and restless legs syndrome (RLS) in Europe and the United States. It is formulated as a once-daily transdermal patch which provides a slow and constant supply of the drug over the course of 24 hours. Like other dopamine agonists, rotigotine has been shown to possess antidepressant effects and may be useful in the treatment of depression as well. (Wikipedia)

   

N-Acetyl desmethyl frovatriptan

3-acetamido-2,3,4,4a,9,9a-hexahydro-1H-carbazole-6-carboxamide

C15H19N3O2 (273.1477)


N-Acetyl desmethyl frovatriptan is a metabolite of frovatriptan. Frovatriptan (trade name Frova) is a triptan drug developed by Vernalis for the treatment of migraine headaches and for short term prevention of menstrual migraine. The product is licensed to Endo Pharmaceuticals in North America and Menarini in Europe. (Wikipedia)

   

4-Methylhexanoylcarnitine

3-[(4-methylhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H27NO4 (273.194)


4-Methylhexanoylcarnitine is an acylcarnitine. More specifically, it is an 4-methylhexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Methylhexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-Methylhexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Methylhexanoylcarnitine

3-[(5-methylhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H27NO4 (273.194)


5-Methylhexanoylcarnitine is an acylcarnitine. More specifically, it is an 5-methylhexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Methylhexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Methylhexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Methylhexanoylcarnitine

3-[(3-methylhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H27NO4 (273.194)


3-Methylhexanoylcarnitine is an acylcarnitine. More specifically, it is an 3-methylhexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Methylhexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-Methylhexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(3E)-Glutaconylcarnitin

3-[(4-carboxybut-3-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C12H19NO6 (273.1212)


(3E)-Glutaconylcarnitin is an acylcarnitine. More specifically, it is an (3E)-pent-3-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (3E)-Glutaconylcarnitin is therefore classified as a short chain AC. As a short-chain acylcarnitine (3E)-Glutaconylcarnitin is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4E)-3-Hydroxyhex-4-enoylcarnitine

3-[(3-hydroxyhex-4-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H23NO5 (273.1576)


(4E)-3-hydroxyhex-4-enoylcarnitine is an acylcarnitine. More specifically, it is an (4E)-3-hydroxyhex-4-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4E)-3-hydroxyhex-4-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (4E)-3-hydroxyhex-4-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Oxohexanoylcarnitine

3-[(3-oxohexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H23NO5 (273.1576)


3-oxohexanoylcarnitine is an acylcarnitine. More specifically, it is an 3-oxohexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-oxohexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-oxohexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Oxohexanoylcarnitine

3-[(5-oxohexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H23NO5 (273.1576)


5-oxohexanoylcarnitine is an acylcarnitine. More specifically, it is an 5-oxohexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-oxohexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-oxohexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

4-Methylpropranolol

1-[(4-methylnaphthalen-1-yl)oxy]-3-[(propan-2-yl)amino]propan-2-ol

C17H23NO2 (273.1729)


   

Hhcfu

5-fluoro-N-(5-hydroxyhexyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-1-carboxamide

C11H16FN3O4 (273.1125)


   

Desmethylcyproheptadine

4-{tricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,9,11,13-heptaen-2-ylidene}piperidine

C20H19N (273.1517)


   

Dextilidine

Ethyl 2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylic acid

C17H23NO2 (273.1729)


   

Mopidralazine

N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(morpholin-4-yl)pyridazin-3-amine

C14H19N5O (273.159)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent

   

N-Desmethyl zolmitriptan

4-({3-[2-(methylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one

C15H19N3O2 (273.1477)


   

Norgalanthamine

9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-ol

C16H19NO3 (273.1365)


   

Prodolic acid

Pyrano[3,4-b]indole-1-aceticacid, 1,3,4,9-tetrahydro-1-propyl-

C16H19NO3 (273.1365)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids

   

indole-3-acetyl-valine

2-[2-(1H-indol-3-yl)acetamido]-3-methylbutanoate

C15H17N2O3- (273.1239)


Indole-3-acetyl-valine is also known as iaa-val. Indole-3-acetyl-valine is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Indole-3-acetyl-valine can be found in a number of food items such as avocado, cupua√ßu, green bean, and guava, which makes indole-3-acetyl-valine a potential biomarker for the consumption of these food products. Indole-3-acetyl-valine is also known as iaa-val. Indole-3-acetyl-valine is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Indole-3-acetyl-valine can be found in a number of food items such as avocado, cupuaçu, green bean, and guava, which makes indole-3-acetyl-valine a potential biomarker for the consumption of these food products.

   

Valyl-Arginine

2-[(2-amino-1-hydroxy-3-methylbutylidene)amino]-5-carbamimidamidopentanoic acid

C11H23N5O3 (273.1801)


   

9-Norpluviine

9-O-Demethylpluviine

C16H19NO3 (273.1365)


   
   
   

Glycocitlone A

Glycocitlone A

C16H19NO3 (273.1365)


   

4,8-dimethoxy-3-(3-methylbut-2-enyl)-1H-quinolin-2-one

4,8-dimethoxy-3-(3-methylbut-2-enyl)-1H-quinolin-2-one

C16H19NO3 (273.1365)


   

SCFVUIUTMITLOC-UHFFFAOYSA-

SCFVUIUTMITLOC-UHFFFAOYSA-

C16H19NO3 (273.1365)


   

Magellaninone

Magellaninone

C17H23NO2 (273.1729)


   
   

Ptelefoliarine

Ptelefoliarine

C16H19NO3 (273.1365)


   

8-(gamma,gamma-dimethylallyloxy)-4-methoxy-N-methyl-2-quinolone

8-(gamma,gamma-dimethylallyloxy)-4-methoxy-N-methyl-2-quinolone

C16H19NO3 (273.1365)


   

10-Norpluviine

10-Norpluviine

C16H19NO3 (273.1365)


   

8-O-Demethylvasconine

(-)-8-Demethylmaritidine

C16H19NO3 (273.1365)


   

SCHEMBL22342125

SCHEMBL22342125

C11H19N3O5 (273.1325)


   

metazachlor OXA

metazachlor OXA

C14H15N3O3 (273.1113)


A monocarboxylic acid that is oxoacetic acid substituted by a (2,6-dimethylphenyl)(1H-pyrazol-1-ylmethyl)amino group at position 2. It is metabolite of the herbicide metazachlor. CONFIDENCE standard compound; EAWAG_UCHEM_ID 706 CONFIDENCE standard compound; INTERNAL_ID 2062

   

Ethyl 2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate

Ethyl 2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate

C17H23NO2 (273.1729)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics N - Nervous system > N02 - Analgesics > N02A - Opioids

   

4-(Phenylazo)diphenylamine

4-(Phenylazo)diphenylamine

C18H15N3 (273.1266)


   

N-(4-fluorophenyl)adamantane-1-carboxamide

N-(4-fluorophenyl)adamantane-1-carboxamide

C17H20FNO (273.1529)


   
   

Maybridge3_005694

Maybridge3_005694

C16H19NO3 (273.1365)


   

DTXSID90891601

DTXSID90891601

C17H23NO2 (273.1729)


   
   

methyl isoplatydesmine

methyl isoplatydesmine

C16H19NO3 (273.1365)


   
   

10-Methoxy-3,12-didehydrogalanthan-1,9-diol #

10-Methoxy-3,12-didehydrogalanthan-1,9-diol #

C16H19NO3 (273.1365)


   

8-O-demethylmaritidine|9-O-Demethylmaritidine

8-O-demethylmaritidine|9-O-Demethylmaritidine

C16H19NO3 (273.1365)


   

DTXSID60556811

DTXSID60556811

C17H23NO2 (273.1729)


   

N-isobutyl-6-(p-methoxyphenyl)hexa-3,5-dienamide

N-isobutyl-6-(p-methoxyphenyl)hexa-3,5-dienamide

C17H23NO2 (273.1729)


   

4-O-Demethylmesembrenon|4-O-Demethylmesembrenone

4-O-Demethylmesembrenon|4-O-Demethylmesembrenone

C16H19NO3 (273.1365)


   
   

Dihydrocrinine

Dihydrocrinine

C16H19NO3 (273.1365)


   
   

1-Methyl-8-methoxy-2-hexylquinolin-4(1H)-one

1-Methyl-8-methoxy-2-hexylquinolin-4(1H)-one

C17H23NO2 (273.1729)


   
   

1,2-O-Isopropylidene,N,5-Di-Ac-alpha-D-Furanose-3-Amino-3-deoxyribose

1,2-O-Isopropylidene,N,5-Di-Ac-alpha-D-Furanose-3-Amino-3-deoxyribose

C12H19NO6 (273.1212)


   

(2E,4E,6E)-7-(2-thienyl)-2,4-6-heptatrienoic acid piperidide|1-[(2E,4E,6E)-1-oxo-7-(2-thienyl)heptatrienyl]piperidine|1-[(2E,4E,6E)-7-(2-thienyl)-2,4,6-heptatrienoyl]piperidine|7-(thiophene)-2E,4E,6E-heptatrienoic acid piperidide|N-piperidineotanthusic acid amide|Otanthus acid piperidide|Otanthus Maritima amide|Otanthussaeure-piperidid

(2E,4E,6E)-7-(2-thienyl)-2,4-6-heptatrienoic acid piperidide|1-[(2E,4E,6E)-1-oxo-7-(2-thienyl)heptatrienyl]piperidine|1-[(2E,4E,6E)-7-(2-thienyl)-2,4,6-heptatrienoyl]piperidine|7-(thiophene)-2E,4E,6E-heptatrienoic acid piperidide|N-piperidineotanthusic acid amide|Otanthus acid piperidide|Otanthus Maritima amide|Otanthussaeure-piperidid

C16H19NOS (273.1187)


   

6-(4-methoxyphenyl)-N-(2-methylpropyl)hexa-2,4-dienamide

6-(4-methoxyphenyl)-N-(2-methylpropyl)hexa-2,4-dienamide

C17H23NO2 (273.1729)


   

Indolizomycin

Indolizomycin

C17H23NO2 (273.1729)


   

3-cinnamoyloxynortropan-6-ol

3-cinnamoyloxynortropan-6-ol

C16H19NO3 (273.1365)


   

(2R)-2,3-epoxy-N-methylatanine

(2R)-2,3-epoxy-N-methylatanine

C16H19NO3 (273.1365)


   

3-(1-hydroxyethyl)-6-(indol-3-ylmethyl)-2,5-diketopiperazine|cyclo(L-Trp-L-Ser-)|cyclo(L-tryptophanyl-L-seryl)|cyclo-L-Trp-L-Ser

3-(1-hydroxyethyl)-6-(indol-3-ylmethyl)-2,5-diketopiperazine|cyclo(L-Trp-L-Ser-)|cyclo(L-tryptophanyl-L-seryl)|cyclo-L-Trp-L-Ser

C14H15N3O3 (273.1113)


   

lycojaponicumin C

lycojaponicumin C

C17H23NO2 (273.1729)


   

lannotinidine F

lannotinidine F

C16H19NO3 (273.1365)


   

SCHEMBL5928738

SCHEMBL5928738

C16H19NO3 (273.1365)


   

Alkaloid KD-1

Alkaloid KD-1

C17H23NO2 (273.1729)


   

(-)-2-Isopropyl-6-methoxy-5-methyl-3,5-dihydro-2H-furo[3,2-c]chinolin-4-on|(-)-2-isopropyl-6-methoxy-5-methyl-3,5-dihydro-2H-furo[3,2-c]quinolin-4-one|2.3.4.5-tetrahydro-2-isopropyl-6-methoxy-5-methyl-4-oxo-furano<3.2-c>chinolin

(-)-2-Isopropyl-6-methoxy-5-methyl-3,5-dihydro-2H-furo[3,2-c]chinolin-4-on|(-)-2-isopropyl-6-methoxy-5-methyl-3,5-dihydro-2H-furo[3,2-c]quinolin-4-one|2.3.4.5-tetrahydro-2-isopropyl-6-methoxy-5-methyl-4-oxo-furano<3.2-c>chinolin

C16H19NO3 (273.1365)


   

Piperlonguminin

Piperlonguminin

C16H19NO3 (273.1365)


   

ACMC-20lw9k

ACMC-20lw9k

C20H19N (273.1517)


   

(8aS,9R,11R,12aS)-6,7,8,8a,9,10,11,12-octahydro-8a-hydroxy-11-methyl-1,9-ethanobenzo[i]quinolizin-13,14-dione|huperzine F

(8aS,9R,11R,12aS)-6,7,8,8a,9,10,11,12-octahydro-8a-hydroxy-11-methyl-1,9-ethanobenzo[i]quinolizin-13,14-dione|huperzine F

C16H19NO3 (273.1365)


   

N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]-2-methylpropanamide

N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]-2-methylpropanamide

C17H23NO2 (273.1729)


   
   

(1S,1R)-1-hydroxy-4-(2,6-dideoxy-beta-D-xylo-hexapyranosyloxy)-2-cyclopentene-1-carboxamide

(1S,1R)-1-hydroxy-4-(2,6-dideoxy-beta-D-xylo-hexapyranosyloxy)-2-cyclopentene-1-carboxamide

C12H19NO6 (273.1212)


   
   

N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]butanamide

N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]butanamide

C17H23NO2 (273.1729)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

oxomaritinamine

oxomaritinamine

C16H19NO3 (273.1365)


   

Norgalantamine

(1S,12S,14R)-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol

C16H19NO3 (273.1365)


Norgalanthamine is a benzazepine. Norgalanthamine is a natural product found in Lycoris squamigera, Hymenocallis rotata, and other organisms with data available. N-Desmethyl Galanthamine is a metabolite of Galanthamine. Galanthamine is a potent acetylcholinesterase (AChE) inhibitor with an IC50 of 500 nM[1][2].

   

Tilidine

Tilidine

C17H23NO2 (273.1729)


N - Nervous system > N02 - Analgesics > N02A - Opioids CONFIDENCE standard compound; EAWAG_UCHEM_ID 3329

   

NVE_274.1802_16.6

NVE_274.1802_16.6

C17H23NO2 (273.1729)


CONFIDENCE Tentative identification: most likely structure (Level 3); INTERNAL_ID 1207

   

4-hydroxy-2-octylquinoline 1-oxide:Series 4 HAQ C8

4-hydroxy-2-octylquinoline 1-oxide:Series 4 HAQ C8

C17H23NO2 (273.1729)


   

Metazachlor OA

Metazachlor OA

C14H15N3O3 (273.1113)


CONFIDENCE standard compound; INTERNAL_ID 2642

   

hexyltyrazolone

hexyltyrazolone

C16H19NO3 (273.1365)


   

(E,E)-Piperlonguminine; AIF; CE0; CorrDec

(E,E)-Piperlonguminine; AIF; CE0; CorrDec

C16H19NO3 (273.1365)


   

(E,E)-Piperlonguminine; AIF; CE10; CorrDec

(E,E)-Piperlonguminine; AIF; CE10; CorrDec

C16H19NO3 (273.1365)


   

(E,E)-Piperlonguminine; AIF; CE30; CorrDec

(E,E)-Piperlonguminine; AIF; CE30; CorrDec

C16H19NO3 (273.1365)


   

(E,E)-Piperlonguminine; AIF; CE0; MS2Dec

(E,E)-Piperlonguminine; AIF; CE0; MS2Dec

C16H19NO3 (273.1365)


   

(E,E)-Piperlonguminine; AIF; CE10; MS2Dec

(E,E)-Piperlonguminine; AIF; CE10; MS2Dec

C16H19NO3 (273.1365)


   

(E,E)-Piperlonguminine; AIF; CE30; MS2Dec

(E,E)-Piperlonguminine; AIF; CE30; MS2Dec

C16H19NO3 (273.1365)


   

O4-Pyridyloxobutyl-thymine

O4-Pyridyloxobutyl-thymine

C14H15N3O3 (273.1113)


   

3-Pyridyloxobutyl-thymine

3-Pyridyloxobutyl-thymine

C14H15N3O3 (273.1113)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

4a-peroxy-tetrahydrobiopterin

4a-peroxy-tetrahydrobiopterin

C9H15N5O5 (273.1073)


   

Arg-val

2-(2-amino-3-methylbutanamido)-5-carbamimidamidopentanoic acid

C11H23N5O3 (273.1801)


A dipeptide formed from L-arginine and L-valine residues.

   

Val-arg

2-(2-amino-5-carbamimidamidopentanamido)-3-methylbutanoic acid

C11H23N5O3 (273.1801)


A dipeptide formed from L-valine and L-asparagine residues.

   

piperlonguminine

(2E,4E)-5-(2H-1,3-benzodioxol-5-yl)-N-(2-methylpropyl)penta-2,4-dienamide

C16H19NO3 (273.1365)


Piperlonguminine is an alkaloid amide isolated from the Piper species. Piperlonguminine shows various biological properties, including anti-inflammatory, antitumor, neuroprotective, anti-platelet, anti-melanogenic, antifungal and antibacterial activities[1][2][3][4]. Piperlonguminine is an alkaloid amide isolated from the Piper species. Piperlonguminine shows various biological properties, including anti-inflammatory, antitumor, neuroprotective, anti-platelet, anti-melanogenic, antifungal and antibacterial activities[1][2][3][4].

   

linalyl anthranilate

Anthranilic acid, 1, 5-dimethyl-1-vinyl-4-hexenyl ester

C17H23NO2 (273.1729)


   

FEMA 3048

2-(4-methylcyclohex-3-en-1-yl)propan-2-yl 2-aminobenzoate

C17H23NO2 (273.1729)


   

Piperamide-C5:1 (2E)

(2E)-5-(2H-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)pent-2-en-1-one

C16H19NO3 (273.1365)


   

1-(p-Methoxyphenyl)-5-piperidino-1-penten-3-one

(E)-1-(4-methoxyphenyl)-5-piperidin-1-ylpent-1-en-3-one;hydrochloride

C17H23NO2 (273.1729)


   

CAR 5:2;O2

(3S)-3-{[(2E)-4-carboxybut-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate

C12H19NO6 (273.1212)


   

CAR 7:0

3-(heptanoyloxy)-4-(trimethylazaniumyl)butanoate

C14H27NO4 (273.194)


   

5-TRIFLUOROMETHYLPYRIDINE-2-BORONIC ACID PINACOL ESTER

5-TRIFLUOROMETHYLPYRIDINE-2-BORONIC ACID PINACOL ESTER

C12H15BF3NO2 (273.1148)


   

ethyl 5-tert-butyl-3-formyl-1H-indole-2-carboxylate

ethyl 5-tert-butyl-3-formyl-1H-indole-2-carboxylate

C16H19NO3 (273.1365)


   

(R)-2-((TERT-BUTOXYCARBONYL)AMINO)-2-((1R,4R)-4-HYDROXYCYCLOHEXYL)ACETIC ACID

(R)-2-((TERT-BUTOXYCARBONYL)AMINO)-2-((1R,4R)-4-HYDROXYCYCLOHEXYL)ACETIC ACID

C13H23NO5 (273.1576)


   

2-N-BOC-Amino-3-(4-tetrahydropyranyl)-propionsaeure

2-N-BOC-Amino-3-(4-tetrahydropyranyl)-propionsaeure

C13H23NO5 (273.1576)


   

3-(6-ethyl-7-methoxy-5-methylimidazo[1,2-a]pyrimidin-2-yl)-5-methyl-1,2,4-oxadiazole

3-(6-ethyl-7-methoxy-5-methylimidazo[1,2-a]pyrimidin-2-yl)-5-methyl-1,2,4-oxadiazole

C13H15N5O2 (273.1226)


   

5-ALLYLOXY-3,6-DIHYDRO-2H-PYRIDINE-1-CARBOXYLIC ACID BENZYL ESTER

5-ALLYLOXY-3,6-DIHYDRO-2H-PYRIDINE-1-CARBOXYLIC ACID BENZYL ESTER

C16H19NO3 (273.1365)


   

4-[3-(1,3-BENZODIOXOL-5-YL)-1,2,4-OXADIAZOL-5-YL]PIPERIDINE

4-[3-(1,3-BENZODIOXOL-5-YL)-1,2,4-OXADIAZOL-5-YL]PIPERIDINE

C14H15N3O3 (273.1113)


   

Tricyclo[3.3.1.13,​7]​decane, 1-​(4-​nitrophenyl)​

Tricyclo[3.3.1.13,​7]​decane, 1-​(4-​nitrophenyl)​

C16H19NO3 (273.1365)


   

5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-2-(TRIFLUOROMETHYL)PYRIDINE

5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-2-(TRIFLUOROMETHYL)PYRIDINE

C12H15BF3NO2 (273.1148)


   

7-Chloro-2-[[[(1S)-2,2-dimethylcyclopropyl]carbonyl]amino]-2-heptenoic acid

7-Chloro-2-[[[(1S)-2,2-dimethylcyclopropyl]carbonyl]amino]-2-heptenoic acid

C13H20ClNO3 (273.1132)


   

4-ALLYL-5-(4-TERT-BUTYLPHENYL)-4H-1,2,4-TRIAZOLE-3-THIOL

4-ALLYL-5-(4-TERT-BUTYLPHENYL)-4H-1,2,4-TRIAZOLE-3-THIOL

C15H19N3S (273.13)


   

BENZYL 4-OXO-2-PROPYL-3,4-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE

BENZYL 4-OXO-2-PROPYL-3,4-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE

C16H19NO3 (273.1365)


   

BENZYL 2-ISOPROPYL-4-OXO-3,4-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE

BENZYL 2-ISOPROPYL-4-OXO-3,4-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE

C16H19NO3 (273.1365)


   

(2S)-2,3,3-trideuterio-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(2,3,4,5,6-pentadeuteriophenyl)propanoic acid

(2S)-2,3,3-trideuterio-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(2,3,4,5,6-pentadeuteriophenyl)propanoic acid

C14H11D8NO4 (273.1816)


   

ISONIPECOTIC ACID, 1-ALLYL-4-PHENYL-, ETHYL ESTER

ISONIPECOTIC ACID, 1-ALLYL-4-PHENYL-, ETHYL ESTER

C17H23NO2 (273.1729)


   

3,4-DIHYDRO-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)ISOQUINOLIN-1(2H)-ONE

3,4-DIHYDRO-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)ISOQUINOLIN-1(2H)-ONE

C15H20BNO3 (273.1536)


   

2-{[1-(tert-Butoxycarbonyl)-4-piperidinyl]-oxy}propanoic acid

2-{[1-(tert-Butoxycarbonyl)-4-piperidinyl]-oxy}propanoic acid

C13H23NO5 (273.1576)


   

2-(1,4-dioxaspiro[4.5]decan-8-yl)-1,2,3,4-tetrahydroisoquinoline

2-(1,4-dioxaspiro[4.5]decan-8-yl)-1,2,3,4-tetrahydroisoquinoline

C17H23NO2 (273.1729)


   

3-methoxycarbonylmethoxy-piperidine-1-carboxylic acid tert-butyl ester

3-methoxycarbonylmethoxy-piperidine-1-carboxylic acid tert-butyl ester

C13H23NO5 (273.1576)


   

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrrolidine

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrrolidine

C16H24BNO2 (273.19)


   

Benzenamine,N-phenyl-4-(2-phenyldiazenyl)-

Benzenamine,N-phenyl-4-(2-phenyldiazenyl)-

C18H15N3 (273.1266)


   

9-((tert-Butoxycarbonyl)amino)nonanoic acid

9-((tert-Butoxycarbonyl)amino)nonanoic acid

C14H27NO4 (273.194)


   

(S)-MORPHOLINE-3,4-DICARBOXYLICACID4-TERT-BUTYLESTER

(S)-MORPHOLINE-3,4-DICARBOXYLICACID4-TERT-BUTYLESTER

C14H15N3O3 (273.1113)


   

5-Trifluoromethylpyridine-3-boronic acid pinacol ester

5-Trifluoromethylpyridine-3-boronic acid pinacol ester

C12H15BF3NO2 (273.1148)


   

1-(5-Nitroquinolin-6-yl)piperidin-4-ol

1-(5-Nitroquinolin-6-yl)piperidin-4-ol

C14H15N3O3 (273.1113)


   

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclopropanamine

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclopropanamine

C16H24BNO2 (273.19)


   

(S)-tert-Butyl 3-(2-ethoxy-2-oxoethyl)morpholine-4-carboxylate

(S)-tert-Butyl 3-(2-ethoxy-2-oxoethyl)morpholine-4-carboxylate

C13H23NO5 (273.1576)


   

(R)-TERT-BUTYL 4-(4-HYDROXYBUTYL)-2,2-DIMETHYLOXAZOLIDINE-3-CARBOXYLATE

(R)-TERT-BUTYL 4-(4-HYDROXYBUTYL)-2,2-DIMETHYLOXAZOLIDINE-3-CARBOXYLATE

C14H27NO4 (273.194)


   

4-(2-cyclohexylethylamino)-2-nitrobenzonitrile

4-(2-cyclohexylethylamino)-2-nitrobenzonitrile

C15H19N3O2 (273.1477)


   

1-(4-Aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1H)-pyridinone

1-(4-Aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1H)-pyridinone

C15H19N3O2 (273.1477)


   

5-Cyclohexyl-3-(3-nitrophenyl)-1,2,4-oxadiazole

5-Cyclohexyl-3-(3-nitrophenyl)-1,2,4-oxadiazole

C14H15N3O3 (273.1113)


   

2-Trifluoromethylpyridine-4-boronic acid pinacol ester

2-Trifluoromethylpyridine-4-boronic acid pinacol ester

C12H15BF3NO2 (273.1148)


   

Naphazoline nitrate

Naphazoline nitrate

C14H15N3O3 (273.1113)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D019141 - Respiratory System Agents > D014663 - Nasal Decongestants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents Naphazoline (Naphthazoline) nitrate is an α-adrenergic receptor agonist. Naphazoline nitrate reduces vascular hyperpermeability and promotes vasoconstriction. Naphazoline nitrate reduces the levels of inflammatory factors (TNF-α, IL-1β and IL-6), cytokines (IFN-γ and IL-4), IgE, GMCSF, and NGF。Naphazoline nitrate can be used for non-bacterial conjunctivitis research[1][2].

   

(1R,4R)-1-(AMINOMETHYL)-4-(4-FLUOROBENZYL)CYCLOHEXANOL HYDROCHLORIDE

(1R,4R)-1-(AMINOMETHYL)-4-(4-FLUOROBENZYL)CYCLOHEXANOL HYDROCHLORIDE

C14H21ClFNO (273.1296)


   

3-(Boc-amino)-3-(4-tetrahydropyranyl)propanoic Acid

3-(Boc-amino)-3-(4-tetrahydropyranyl)propanoic Acid

C13H23NO5 (273.1576)


   

1-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PYRROLIDINE

1-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PYRROLIDINE

C16H24BNO2 (273.19)


   

N-BIS(TERT-BUTYLPROPIONATE)AMINE

N-BIS(TERT-BUTYLPROPIONATE)AMINE

C14H27NO4 (273.194)


   

Benzenemethanamine,N-phenyl-N-(phenylmethyl)-

Benzenemethanamine,N-phenyl-N-(phenylmethyl)-

C20H19N (273.1517)


   

(R)-2-(diphenylmethyl)pyrrolidine hydrochloride

(R)-2-(diphenylmethyl)pyrrolidine hydrochloride

C17H20ClN (273.1284)


   

2-{2-[3-(trifluoromethyl)phenoxy]ethyl}piperidine

2-{2-[3-(trifluoromethyl)phenoxy]ethyl}piperidine

C14H18F3NO (273.134)


   

1-(Triisopropylsilyl)-1H-indole

1-(Triisopropylsilyl)-1H-indole

C17H27NSi (273.1913)


   

tert-butyl 4,4-bis(2-hydroxyethyl)piperidine-1-carboxylate

tert-butyl 4,4-bis(2-hydroxyethyl)piperidine-1-carboxylate

C14H27NO4 (273.194)


   

1-BOC-4-(METHOXYCARBONYL)PYRROLIDINE-3-CARBOXYLIC ACID

1-BOC-4-(METHOXYCARBONYL)PYRROLIDINE-3-CARBOXYLIC ACID

C12H19NO6 (273.1212)


   

6-PHENETHYLCARBAMOYL-CYCLOHEX-3-ENECARBOXYLIC ACID

6-PHENETHYLCARBAMOYL-CYCLOHEX-3-ENECARBOXYLIC ACID

C16H19NO3 (273.1365)


   

(4R,6R)-tert-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate

(4R,6R)-tert-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate

C14H27NO4 (273.194)


   

ETHYL 2-ISOPROPOXY-4-METHOXYBENZIMIDATE HYDROCHLORIDE

ETHYL 2-ISOPROPOXY-4-METHOXYBENZIMIDATE HYDROCHLORIDE

C13H20ClNO3 (273.1132)


   

4,4-Diphenylpiperidine hydrochloride

4,4-Diphenylpiperidine hydrochloride

C17H20ClN (273.1284)


   

tert-Butyl 4-methoxynaphthalen-2-ylcarbamate

tert-Butyl 4-methoxynaphthalen-2-ylcarbamate

C16H19NO3 (273.1365)


   

1-Methyl-1-propylpyrrolidinium hexafluorophosphate

1-Methyl-1-propylpyrrolidinium hexafluorophosphate

C8H18F6NP (273.1081)


   

2-Fluoro-4-(trans-4-pentylcyclohexyl)-benzonitrile

2-Fluoro-4-(trans-4-pentylcyclohexyl)-benzonitrile

C18H24FN (273.1893)


   

5-Cyclohexyl-3-(4-nitrophenyl)-1,2,4-oxadiazole

5-Cyclohexyl-3-(4-nitrophenyl)-1,2,4-oxadiazole

C14H15N3O3 (273.1113)


   

1-Piperidinecarboxylic acid, 4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-, ethyl ester

1-Piperidinecarboxylic acid, 4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-, ethyl ester

C15H19N3O2 (273.1477)


   

3-(3-CYCLOPROPYL-1-OXOPROPYL)-4(R)-(1-PHENYLMETHYL)-2-OXAZOLIDINONE

3-(3-CYCLOPROPYL-1-OXOPROPYL)-4(R)-(1-PHENYLMETHYL)-2-OXAZOLIDINONE

C16H19NO3 (273.1365)


   

2-Amino-8-benzyl-2,8-diazaspiro[4.5]decane-1,3-dione

2-Amino-8-benzyl-2,8-diazaspiro[4.5]decane-1,3-dione

C15H19N3O2 (273.1477)


   

4-Methyl 1-(2-methyl-2-propanyl) 4-methoxy-1,4-piperidinedicarbox ylate

4-Methyl 1-(2-methyl-2-propanyl) 4-methoxy-1,4-piperidinedicarbox ylate

C13H23NO5 (273.1576)


   

N,N-Bis(M-tolyl)benzenaMine

N,N-Bis(M-tolyl)benzenaMine

C20H19N (273.1517)


   

ethyl prop-2-enoate,N-(hydroxymethyl)prop-2-enamide,prop-2-enoic acid

ethyl prop-2-enoate,N-(hydroxymethyl)prop-2-enamide,prop-2-enoic acid

C12H19NO6 (273.1212)


   

tert-butyl N-[2-(2,4-difluorophenyl)-2-hydroxyethyl]carbamate

tert-butyl N-[2-(2,4-difluorophenyl)-2-hydroxyethyl]carbamate

C13H17F2NO3 (273.1176)


   

4-DIMETHYLAMINOMETHYL-THIOPHENE-2-CARBALDEHYDE

4-DIMETHYLAMINOMETHYL-THIOPHENE-2-CARBALDEHYDE

C14H21Cl2N (273.1051)


   

4,4-Dimethyltriphenylamine

4,4-Dimethyltriphenylamine

C20H19N (273.1517)


   

3,4-Dimethyltriphenylamine

3,4-Dimethyltriphenylamine

C20H19N (273.1517)


   

3,5-dimethyl-N-phenylaniline

3,5-dimethyl-N-phenylaniline

C20H19N (273.1517)


   

4-Ethylphenyl 4-trans-propylcyclohexylcarboxylate

4-Ethylphenyl 4-trans-propylcyclohexylcarboxylate

C18H25O2- (273.1854)


   

3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)aniline

3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)aniline

C13H18F3N3 (273.1453)


   

2-CARBOXYMETHYL-5,5-DIMETHYL-MORPHOLINE-4-CARBOXYLIC ACID TERT-BUTYL ESTER

2-CARBOXYMETHYL-5,5-DIMETHYL-MORPHOLINE-4-CARBOXYLIC ACID TERT-BUTYL ESTER

C13H23NO5 (273.1576)


   

8-Hydroxy-1,1,7,7-tetramethyljulolidine-9-carboxaldehyde

8-Hydroxy-1,1,7,7-tetramethyljulolidine-9-carboxaldehyde

C17H23NO2 (273.1729)


   

N-Cbz-9-azabicyclo[3.3.1]nonan-3-one

N-Cbz-9-azabicyclo[3.3.1]nonan-3-one

C16H19NO3 (273.1365)


   

3-Amino-6-(4-methylphenyl)pyrazinecarboxylicacidethylester-4-oxide

3-Amino-6-(4-methylphenyl)pyrazinecarboxylicacidethylester-4-oxide

C14H15N3O3 (273.1113)


   

Oxaflozane

Oxaflozane

C14H18F3NO (273.134)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants

   

(4S,trans)-1,1-Dimethylethyl-6-aminoethyl-2,2-dimethyl-1,3-dioxane-4-acetate

(4S,trans)-1,1-Dimethylethyl-6-aminoethyl-2,2-dimethyl-1,3-dioxane-4-acetate

C14H27NO4 (273.194)


   

2-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl]-1,3,4-oxadiazole

2-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl]-1,3,4-oxadiazole

C13H16BN3O3 (273.1285)


   

Propanamide, 2-methyl-N-[2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethyl]

Propanamide, 2-methyl-N-[2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethyl]

C17H23NO2 (273.1729)


   

Ethyl N-Boc-5-hydroxypiperidine-3-carboxylate

Ethyl N-Boc-5-hydroxypiperidine-3-carboxylate

C13H23NO5 (273.1576)


   

4-(N,N-Diphenylamino)benzaldehyde

4-(N,N-Diphenylamino)benzaldehyde

C19H15NO (273.1154)


   

1-[3-(4-p-tolyl-piperazin-1-yl)-azetidin-1-yl]-ethanone

1-[3-(4-p-tolyl-piperazin-1-yl)-azetidin-1-yl]-ethanone

C16H23N3O (273.1841)


   

6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1H-qu inolin-2-one

6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1H-qu inolin-2-one

C15H20BNO3 (273.1536)


   

(2S)-1-TERT-BUTYL 2-ETHYL 5-METHOXYPYRROLIDINE-1,2-DICARBOXYLATE

(2S)-1-TERT-BUTYL 2-ETHYL 5-METHOXYPYRROLIDINE-1,2-DICARBOXYLATE

C13H23NO5 (273.1576)


   

1-(1-benzylpiperidin-4-yl)-1,3-diazinan-2-one

1-(1-benzylpiperidin-4-yl)-1,3-diazinan-2-one

C16H23N3O (273.1841)


   

2-(TERT-BUTYL)-7-HYDRAZINO-5-(TRIFLUOROMETHYL)PYRAZOLO[1,5-A]PYRIMIDINE

2-(TERT-BUTYL)-7-HYDRAZINO-5-(TRIFLUOROMETHYL)PYRAZOLO[1,5-A]PYRIMIDINE

C11H14F3N5 (273.1201)


   

5-(4-hydroxyphenyl)-5-phenyl-d5-hydantoin-15n2

5-(4-hydroxyphenyl)-5-phenyl-d5-hydantoin-15n2

C15H7D5N2O3 (273.1162)


   

4-Trifluoromethyl-pyridine-3-boronic acid

4-Trifluoromethyl-pyridine-3-boronic acid

C12H15BF3NO2 (273.1148)


   

5-diethylaminomethyl-2-phenyl-furan-3-carboxylic acid

5-diethylaminomethyl-2-phenyl-furan-3-carboxylic acid

C16H19NO3 (273.1365)


   

(N-AcrylaMidophenyl)boronic acid pinacol ester

(N-AcrylaMidophenyl)boronic acid pinacol ester

C15H20BNO3 (273.1536)


   

(3aS,5R,6S,6aS)-[6-hydroxy-2,2-dimethyltetrahydrofuro[3,2-d][1,3]dioxol-5-yl]-(morpholino)methanone

(3aS,5R,6S,6aS)-[6-hydroxy-2,2-dimethyltetrahydrofuro[3,2-d][1,3]dioxol-5-yl]-(morpholino)methanone

C12H19NO6 (273.1212)


   

6-(trifluoromethyl)pyridine-2-boronic acid pinacol ester

6-(trifluoromethyl)pyridine-2-boronic acid pinacol ester

C12H15BF3NO2 (273.1148)


   

[2-(3,4-DIFLUOROPHENYL)-2-HYDROXYETHYL]-CARBAMIC ACID 1,1-DIMETHYLETHYL ESTER

[2-(3,4-DIFLUOROPHENYL)-2-HYDROXYETHYL]-CARBAMIC ACID 1,1-DIMETHYLETHYL ESTER

C13H17F2NO3 (273.1176)


   

Mavacamten

Mavacamten

C15H19N3O2 (273.1477)


C - Cardiovascular system > C01 - Cardiac therapy

   

rac Viloxazine-d5 Hydrochloride

rac Viloxazine-d5 Hydrochloride

C13H20ClNO3 (273.1132)


   

7,7-azanediyldiheptanoic acid

7,7-azanediyldiheptanoic acid

C14H27NO4 (273.194)


   

N-Acetyl Retigabine

N-Acetyl Retigabine

C15H16FN3O (273.1277)


   

Viloxazine hydrochloride

2-[(2-ethoxyphenoxy)methyl]morpholine hydrochloride

C13H20ClNO3 (273.1132)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C185721 - Norepinephrine Reuptake Inhibitor D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators

   

7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinolin-1(2H)-one

7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinolin-1(2H)-one

C15H20BNO3 (273.1536)


   

6-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

6-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

C15H20BNO3 (273.1536)


   

4-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

4-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

C15H20BNO3 (273.1536)


   

7-methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

7-methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

C15H20BNO3 (273.1536)


   

2-methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4-tetrahydroisoquinoline

2-methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4-tetrahydroisoquinoline

C16H24BNO2 (273.19)


   

(2-AMINOETHOXY)DIPHENYLBORANE

(2-AMINOETHOXY)DIPHENYLBORANE

C12H21BClNO3 (273.1303)


   

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylamide

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylamide

C15H20BNO3 (273.1536)


   

D-ASPARTIC ACID, N-[(1,1-DIMETHYLETHOXY)CARBONYL]-, 4-(2-PROPENYL) ESTER

D-ASPARTIC ACID, N-[(1,1-DIMETHYLETHOXY)CARBONYL]-, 4-(2-PROPENYL) ESTER

C12H19NO6 (273.1212)


   

4-[2-(Methyl-2-pyridinyl)amino]ethoxyl nitrobenzene

4-[2-(Methyl-2-pyridinyl)amino]ethoxyl nitrobenzene

C14H15N3O3 (273.1113)


   

2-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE

2-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE

C16H24BNO2 (273.19)


   

2-(Benzyloxy)-2-(2-naphthyl)acetonitrile

2-(Benzyloxy)-2-(2-naphthyl)acetonitrile

C19H15NO (273.1154)


   

3-(4-Benzyloxyphenoxy)-2-hydroxypropanamine

3-(4-Benzyloxyphenoxy)-2-hydroxypropanamine

C16H19NO3 (273.1365)


   

1-[(tert-butoxy)carbonyl]-3-(ethoxycarbonyl)azetidine-3-carboxylic acid

1-[(tert-butoxy)carbonyl]-3-(ethoxycarbonyl)azetidine-3-carboxylic acid

C12H19NO6 (273.1212)


   

5-Methoxy-1H-indole-2-boronic acid pinacol ester

5-Methoxy-1H-indole-2-boronic acid pinacol ester

C15H20BNO3 (273.1536)


   

4-[(6-nitroquinolin-2-yl)methyl]morpholine

4-[(6-nitroquinolin-2-yl)methyl]morpholine

C14H15N3O3 (273.1113)


   

1-[3-amino-5-[4-(tert-butyl)phenyl]-2-thienyl]ethan-1-one

1-[3-amino-5-[4-(tert-butyl)phenyl]-2-thienyl]ethan-1-one

C16H19NOS (273.1187)


   

Ac-Ala-Ala-Ala-OH

Ac-Ala-Ala-Ala-OH

C11H19N3O5 (273.1325)


   

2,4-dimethyl-N,N-diphenylaniline

2,4-dimethyl-N,N-diphenylaniline

C20H19N (273.1517)


   

2-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}ethanamine

2-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}ethanamine

C13H18F3N3 (273.1453)


   

boc-asp(oall)-oh

boc-asp(oall)-oh

C12H19NO6 (273.1212)


   

4-pyren-1-ylbutan-1-amine

4-pyren-1-ylbutan-1-amine

C20H19N (273.1517)


   

4-(4-Methylpiperazin-1-ylmethyl)-3-trifluoromethylaniline

4-(4-Methylpiperazin-1-ylmethyl)-3-trifluoromethylaniline

C13H18F3N3 (273.1453)


   

2-oxo-7-aza-spiro[3.5]nonane-7-carboxylic acid benzyl ester

2-oxo-7-aza-spiro[3.5]nonane-7-carboxylic acid benzyl ester

C16H19NO3 (273.1365)


   

1-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole

1-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole

C16H23N3O (273.1841)


   

Dextilidine

Dextilidine

C17H23NO2 (273.1729)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics N - Nervous system > N02 - Analgesics > N02A - Opioids

   

s-Triazine, 1,2-dihydro-1-(p-butylphenyl)-4,6-diamino-2,2-dimethyl-

s-Triazine, 1,2-dihydro-1-(p-butylphenyl)-4,6-diamino-2,2-dimethyl-

C15H23N5 (273.1953)


   

Desmethylcyproheptadine

Desmethylcyproheptadine

C20H19N (273.1517)


   

Tilidine, (-)-

Tilidine, (-)-

C17H23NO2 (273.1729)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics N - Nervous system > N02 - Analgesics > N02A - Opioids

   

Tropanserin

Tropanserin

C17H23NO2 (273.1729)


C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist Tropanserin is a serotoninergic active compound, as well as a 5HT3 receptor antagonist. Tropanserin modulates Cardio-respiratory reflex effects of an exogenous serotonin challenge[1].

   

Etifelmine hydrochloride

Etifelmine hydrochloride

C17H20ClN (273.1284)


   

L-Alanine, L-alanyl-L-leucyl-

L-Alanine, L-alanyl-L-leucyl-

C12H23N3O4 (273.1688)


   

(E)-1-(4-methylphenyl)-3-quinolin-6-ylprop-2-en-1-one

(E)-1-(4-methylphenyl)-3-quinolin-6-ylprop-2-en-1-one

C19H15NO (273.1154)


   

L-Alanyl-L-alanyl-L-leucine

L-Alanyl-L-alanyl-L-leucine

C12H23N3O4 (273.1688)


   

1-Butyl-3-(2-hydroxyethylamino)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile

1-Butyl-3-(2-hydroxyethylamino)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile

C16H23N3O (273.1841)


   

5-Dihydrobenzofuranpyrovalerone

5-Dihydrobenzofuranpyrovalerone

C17H23NO2 (273.1729)


   

N-(2-oxolanylmethyl)-3-(1-tetrazolyl)benzamide

N-(2-oxolanylmethyl)-3-(1-tetrazolyl)benzamide

C13H15N5O2 (273.1226)


   

Glycyl-L-valyl-L-valine

Glycyl-L-valyl-L-valine

C12H23N3O4 (273.1688)


   

Evaclin; Evadol; Isodianidylethanolamine; LC 2

Evaclin; Evadol; Isodianidylethanolamine; LC 2

C16H19NO3 (273.1365)


   

5-(1,3-Benzodioxol-5-yl)-N,N-diethyl-2,4-pentadienamide

5-(1,3-Benzodioxol-5-yl)-N,N-diethyl-2,4-pentadienamide

C16H19NO3 (273.1365)


   

Naphthalen-1-yl methyl(trimethylsilyl)carbamate

Naphthalen-1-yl methyl(trimethylsilyl)carbamate

C15H19NO2Si (273.1185)


   

[(2-Ethoxy-1-naphthoyl)amino]methylboronic acid

[(2-Ethoxy-1-naphthoyl)amino]methylboronic acid

C14H16BNO4 (273.1172)


   

N-{[(2s,3s)-3-(Ethoxycarbonyl)oxiran-2-Yl]carbonyl}-L-Isoleucine

N-{[(2s,3s)-3-(Ethoxycarbonyl)oxiran-2-Yl]carbonyl}-L-Isoleucine

C12H19NO6 (273.1212)


   

3-Amino-3-benzyl-9-carboxamide[4.3.0]bicyclo-1,6-diazanonan-2-one

3-Amino-3-benzyl-9-carboxamide[4.3.0]bicyclo-1,6-diazanonan-2-one

C15H19N3O2 (273.1477)


   

5-Acetamido-5,6-Dihydro-4-Hydroxy-6-Isobutoxy-4h-Pyran-2-Carboxylic Acid

5-Acetamido-5,6-Dihydro-4-Hydroxy-6-Isobutoxy-4h-Pyran-2-Carboxylic Acid

C12H19NO6 (273.1212)


   

Prodolic acid

Pyrano[3,4-b]indole-1-aceticacid, 1,3,4,9-tetrahydro-1-propyl-

C16H19NO3 (273.1365)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids

   

5950-12-9

(2E,4E)-5-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)penta-2,4-dienamide

C16H19NO3 (273.1365)


Piperlonguminine is an alkaloid amide isolated from the Piper species. Piperlonguminine shows various biological properties, including anti-inflammatory, antitumor, neuroprotective, anti-platelet, anti-melanogenic, antifungal and antibacterial activities[1][2][3][4]. Piperlonguminine is an alkaloid amide isolated from the Piper species. Piperlonguminine shows various biological properties, including anti-inflammatory, antitumor, neuroprotective, anti-platelet, anti-melanogenic, antifungal and antibacterial activities[1][2][3][4].

   

4-(4-Cyclohexylanilino)-4-oxobut-2-enoic acid

4-(4-Cyclohexylanilino)-4-oxobut-2-enoic acid

C16H19NO3 (273.1365)


   

N-[2-(cyclohex-1-en-1-yl)-2-(4-methoxyphenyl)ethyl]acetamide

N-[2-(cyclohex-1-en-1-yl)-2-(4-methoxyphenyl)ethyl]acetamide

C17H23NO2 (273.1729)


   

4-Methoxy-9-azatetracyclo[7.5.2.01,10.02,7]hexadeca-2,4,6,13-tetraene-5,12-diol

4-Methoxy-9-azatetracyclo[7.5.2.01,10.02,7]hexadeca-2,4,6,13-tetraene-5,12-diol

C16H19NO3 (273.1365)


   
   

3-Geranyl-4-hydroxybenzoate

3-Geranyl-4-hydroxybenzoate

C17H21O3- (273.1491)


   

N(2)-(3-carboxylatopropionyl)-L-arginine(1-)

N(2)-(3-carboxylatopropionyl)-L-arginine(1-)

C10H17N4O5- (273.1199)


An N-acyl-L-alpha-amino acid anion that is the conjugate base of N(2)-succinyl-L-arginine, arising from deprotonation of the carboxy groups and protonation of the amino group; major species at pH 7.3.

   

(9Z,12Z,15Z)-octadecatrien-6-ynoate

(9Z,12Z,15Z)-octadecatrien-6-ynoate

C18H25O2- (273.1854)


   
   

(10bS,4aR)-oxomaritinamine

(10bS,4aR)-oxomaritinamine

C16H19NO3 (273.1365)


   

(10bR,4aS)-oxomaritinamine

(10bR,4aS)-oxomaritinamine

C16H19NO3 (273.1365)


   

Methylglutaconyl hydroxy ornithine

Methylglutaconyl hydroxy ornithine

C11H17N2O6- (273.1087)


   

N(2)-(3-hydroxy-3-methylhexanoyl)-L-glutaminate

N(2)-(3-hydroxy-3-methylhexanoyl)-L-glutaminate

C12H21N2O5- (273.145)


   

N-methylnorbelladine

N-methylnorbelladine

C16H19NO3 (273.1365)


   

L-alanyl-(2S,3E)-amino-4-methoxy-but-3-enoyl-L-alanine

L-alanyl-(2S,3E)-amino-4-methoxy-but-3-enoyl-L-alanine

C11H19N3O5 (273.1325)


   

(2S,3S,7R)-2,3-diamino-8-(2-amino-4,5-dihydro-1H-imidazol-5-yl)-7-hydroxyoctanoic acid

(2S,3S,7R)-2,3-diamino-8-(2-amino-4,5-dihydro-1H-imidazol-5-yl)-7-hydroxyoctanoic acid

C11H23N5O3 (273.1801)


   

(2S)-2-[[(E,2S)-2-[[(2S)-2-aminopropanoyl]amino]-4-methoxybut-3-enoyl]amino]propanoic acid

(2S)-2-[[(E,2S)-2-[[(2S)-2-aminopropanoyl]amino]-4-methoxybut-3-enoyl]amino]propanoic acid

C11H19N3O5 (273.1325)


   

3-Oxohexanoylcarnitine

3-Oxohexanoylcarnitine

C13H23NO5 (273.1576)


   

5-Oxohexanoylcarnitine

5-Oxohexanoylcarnitine

C13H23NO5 (273.1576)


   

4-Methylhexanoylcarnitine

4-Methylhexanoylcarnitine

C14H27NO4 (273.194)


   

5-Methylhexanoylcarnitine

5-Methylhexanoylcarnitine

C14H27NO4 (273.194)


   

3-Methylhexanoylcarnitine

3-Methylhexanoylcarnitine

C14H27NO4 (273.194)


   

(3E)-Glutaconylcarnitin

(3E)-Glutaconylcarnitin

C12H19NO6 (273.1212)


   

(4E)-3-Hydroxyhex-4-enoylcarnitine

(4E)-3-Hydroxyhex-4-enoylcarnitine

C13H23NO5 (273.1576)


   

8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3,5-dimethylbenzoate

8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3,5-dimethylbenzoate

C17H23NO2 (273.1729)


   

2-[[1-(4-Ethoxyphenyl)-2,5-dioxo-3-pyrrolidinyl]amino]acetonitrile

2-[[1-(4-Ethoxyphenyl)-2,5-dioxo-3-pyrrolidinyl]amino]acetonitrile

C14H15N3O3 (273.1113)


   

N-Decanoyl-L-Homoserine

N-Decanoyl-L-Homoserine

C14H27NO4 (273.194)


   
   

1-(3-Pyridin-4-yl-4-oxa-1,2-diaza-spiro[4.6]undec-2-en-1-yl)-ethanone

1-(3-Pyridin-4-yl-4-oxa-1,2-diaza-spiro[4.6]undec-2-en-1-yl)-ethanone

C15H19N3O2 (273.1477)


   

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1,5-dimethyl-4-pyrazolecarboxamide

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1,5-dimethyl-4-pyrazolecarboxamide

C14H15N3O3 (273.1113)


   

N-[[(cyclohexylamino)-sulfanylidenemethyl]amino]carbamic acid tert-butyl ester

N-[[(cyclohexylamino)-sulfanylidenemethyl]amino]carbamic acid tert-butyl ester

C12H23N3O2S (273.1511)


   

4-[(2-Methoxy-1-naphthalenyl)methyl]thiomorpholine

4-[(2-Methoxy-1-naphthalenyl)methyl]thiomorpholine

C16H19NOS (273.1187)


   
   
   
   
   
   
   

O-glutaconyl-L-carnitine

O-glutaconyl-L-carnitine

C12H19NO6 (273.1212)


An O-acyl-L-carnitine where the acyl group specified is glutaconyl.

   

3-[1-(pentylamino)ethylidene]-3,4-dihydro-2H-1-benzopyran-2,4-dione

3-[1-(pentylamino)ethylidene]-3,4-dihydro-2H-1-benzopyran-2,4-dione

C16H19NO3 (273.1365)


   

1-methyl-3-(6,7,8,9-tetrahydro-5H-carbazol-3-ylmethyl)thiourea

1-methyl-3-(6,7,8,9-tetrahydro-5H-carbazol-3-ylmethyl)thiourea

C15H19N3S (273.13)


   

1-[2-[2-(2,3-dihydro-1H-inden-5-yloxy)ethoxy]ethyl]-1,2,4-triazole

1-[2-[2-(2,3-dihydro-1H-inden-5-yloxy)ethoxy]ethyl]-1,2,4-triazole

C15H19N3O2 (273.1477)


   

4-(2,4-dimethoxyphenyl)-3-methyl-4,5-dihydro-2H-pyrrolo[3,4-c]pyrazol-6-one

4-(2,4-dimethoxyphenyl)-3-methyl-4,5-dihydro-2H-pyrrolo[3,4-c]pyrazol-6-one

C14H15N3O3 (273.1113)


   

2-heptyl-1-methoxy-4(1H)-quinolinone

2-heptyl-1-methoxy-4(1H)-quinolinone

C17H23NO2 (273.1729)


   
   
   
   
   
   
   
   
   
   

1-[4-(2-Methoxyphenoxy)but-2-ynyl]azepane

1-[4-(2-Methoxyphenoxy)but-2-ynyl]azepane

C17H23NO2 (273.1729)


   

N-methyl-3-[3-(4-propan-2-ylphenyl)-1,2,4-oxadiazol-5-yl]propanamide

N-methyl-3-[3-(4-propan-2-ylphenyl)-1,2,4-oxadiazol-5-yl]propanamide

C15H19N3O2 (273.1477)


   

(4-Tert-butylphenyl) 3,5-dimethyl-1,2-oxazole-4-carboxylate

(4-Tert-butylphenyl) 3,5-dimethyl-1,2-oxazole-4-carboxylate

C16H19NO3 (273.1365)


   

(3R,8Z,11S)-11-methyl-3-phenyl-1-oxa-4-azacyclododec-8-en-12-one

(3R,8Z,11S)-11-methyl-3-phenyl-1-oxa-4-azacyclododec-8-en-12-one

C17H23NO2 (273.1729)


   
   
   
   
   
   

O-glutaconylcarnitine

O-glutaconylcarnitine

C12H19NO6 (273.1212)


An O-acylcarnitine in which the acyl group specified is glutaconyl.

   

N-dodecanoyl-(2S)-hydroxyglycine

N-dodecanoyl-(2S)-hydroxyglycine

C14H27NO4 (273.194)


   

(E)-5-acetyl-3-(1-(2,2-dimethylhydrazineyl)propylidene)indolin-2-one

(E)-5-acetyl-3-(1-(2,2-dimethylhydrazineyl)propylidene)indolin-2-one

C15H19N3O2 (273.1477)


   

(2E)-7-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]hept-2-enoate

(2E)-7-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]hept-2-enoate

C13H21O6- (273.1338)


   

(E,6R)-6-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyhept-2-enoate

(E,6R)-6-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyhept-2-enoate

C13H21O6- (273.1338)


   

[(2S)-1-(1H-indol-3-yl)-4-methyl-3-oxopentan-2-yl] acetate

[(2S)-1-(1H-indol-3-yl)-4-methyl-3-oxopentan-2-yl] acetate

C16H19NO3 (273.1365)


   

3-[3-(4-Acetamidobutylamino)propylamino]-3-oxopropanoic acid

3-[3-(4-Acetamidobutylamino)propylamino]-3-oxopropanoic acid

C12H23N3O4 (273.1688)


   

3-[4-(3-Acetamidopropylamino)butylamino]-3-oxopropanoic acid

3-[4-(3-Acetamidopropylamino)butylamino]-3-oxopropanoic acid

C12H23N3O4 (273.1688)


   

L-Pyroglutamic acid-DI-tms

L-Pyroglutamic acid-DI-tms

C11H23NO3Si2 (273.1216)


   

N-Acetyl-alanyl-alanyl-glycine methyl ester

N-Acetyl-alanyl-alanyl-glycine methyl ester

C11H19N3O5 (273.1325)


   

N-Acetyl-glycyl-alanyl-alanine methyl ester

N-Acetyl-glycyl-alanyl-alanine methyl ester

C11H19N3O5 (273.1325)


   

N-Trimethylsilylpiperidine-4-carboxylic acid trimethylsilyl ester

N-Trimethylsilylpiperidine-4-carboxylic acid trimethylsilyl ester

C12H27NO2Si2 (273.158)


   

1-(Trimethylsilyl)-3-piperidinecarboxylic acid trimethylsilyl ester

1-(Trimethylsilyl)-3-piperidinecarboxylic acid trimethylsilyl ester

C12H27NO2Si2 (273.158)


   

(-)-8-Demethylmaritidine

(-)-8-Demethylmaritidine

C16H19NO3 (273.1365)


   

N-Desmethylzolmitriptan

N-Desmethylzolmitriptan

C15H19N3O2 (273.1477)


   

O-heptanoylcarnitine

O-heptanoylcarnitine

C14H27NO4 (273.194)


An O-acylcarnitine that is the O-heptanoyl derivative of carnitine.

   
   

alpha-Terpinyl anthranilate

alpha-Terpinyl anthranilate

C17H23NO2 (273.1729)


   

Glutaconylcarnitine

Glutaconylcarnitine

C12H19NO6 (273.1212)


   

(2E)-Piperamide-C5:1

(2E)-Piperamide-C5:1

C16H19NO3 (273.1365)


   

N-Despropyl-rotigotine

N-Despropyl-rotigotine

C16H19NOS (273.1187)


   

N-Acetyl desmethyl frovatriptan

N-Acetyl desmethyl frovatriptan

C15H19N3O2 (273.1477)


   

tropanyl 3,5-dimethylbenzoate

tropanyl 3,5-dimethylbenzoate

C17H23NO2 (273.1729)


A tropane alkaloid that consists of tropine in which the hydrogen of the hydroxy function is substituted by a 3,5-dimethylbenzoyl group.

   

ascr#7(1-)

ascr#7(1-)

C13H21O6 (273.1338)


Conjugate base of ascr#7

   

oscr#7(1-)

oscr#7(1-)

C13H21O6 (273.1338)


A hydroxy fatty acid ascaroside anion resulting from the deprotonation of the carboxy group of oscr#7. The conjugate base of oscr#7 and the major species at pH 7.3.

   

2-Heptyl-1-methoxyquinolin-4(1H)-one

2-Heptyl-1-methoxyquinolin-4(1H)-one

C17H23NO2 (273.1729)


   
   
   
   
   

NA-Ser 11:0

NA-Ser 11:0

C14H27NO4 (273.194)


   

NA-Thr 10:0

NA-Thr 10:0

C14H27NO4 (273.194)


   
   
   
   
   
   
   

1-[(3r)-2,3-dihydroxy-5-(3-methylbut-2-en-1-yl)indol-3-yl]propan-2-one

1-[(3r)-2,3-dihydroxy-5-(3-methylbut-2-en-1-yl)indol-3-yl]propan-2-one

C16H19NO3 (273.1365)


   

5-(2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)pent-2-en-1-one

5-(2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)pent-2-en-1-one

C16H19NO3 (273.1365)


   

9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl 2-phenylacetate

9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl 2-phenylacetate

C16H19NO3 (273.1365)


   

(1r,10r,12s)-4-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-5,12-diol

(1r,10r,12s)-4-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-5,12-diol

C16H19NO3 (273.1365)


   

4-{2-[(5-methoxy-2-methylcyclohex-2-en-1-yl)(methyl)amino]ethenyl}phenol

4-{2-[(5-methoxy-2-methylcyclohex-2-en-1-yl)(methyl)amino]ethenyl}phenol

C17H23NO2 (273.1729)


   

(2r)-2-(2-methoxypropan-2-yl)-9-methyl-2h,3h-furo[2,3-b]quinolin-4-one

(2r)-2-(2-methoxypropan-2-yl)-9-methyl-2h,3h-furo[2,3-b]quinolin-4-one

C16H19NO3 (273.1365)


   

4-methoxy-1-methyl-3-(3-methyl-2-oxobutyl)quinolin-2-one

4-methoxy-1-methyl-3-(3-methyl-2-oxobutyl)quinolin-2-one

C16H19NO3 (273.1365)


   

(10s,12s)-5-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-4,12-diol

(10s,12s)-5-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-4,12-diol

C16H19NO3 (273.1365)


   

(2e,4e)-6-(4-methoxyphenyl)-n-(2-methylpropyl)hexa-2,4-dienimidic acid

(2e,4e)-6-(4-methoxyphenyl)-n-(2-methylpropyl)hexa-2,4-dienimidic acid

C17H23NO2 (273.1729)


   

5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-trien-15-ol

5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-trien-15-ol

C16H19NO3 (273.1365)


   

(1s,15r,16r)-4-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraene-5,15-diol

(1s,15r,16r)-4-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraene-5,15-diol

C16H19NO3 (273.1365)


   

5,14-dimethyl-5-azatetracyclo[7.7.0.0¹,¹².0³,⁸]hexadec-14-ene-10,16-dione

5,14-dimethyl-5-azatetracyclo[7.7.0.0¹,¹².0³,⁸]hexadec-14-ene-10,16-dione

C17H23NO2 (273.1729)


   

(3e)-4-{2-[(1e)-3-hydroxyhex-1-en-1-yl]-4-methylphenyl}but-3-enimidic acid

(3e)-4-{2-[(1e)-3-hydroxyhex-1-en-1-yl]-4-methylphenyl}but-3-enimidic acid

C17H23NO2 (273.1729)


   

(2z,4z)-5-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)penta-2,4-dienimidic acid

(2z,4z)-5-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)penta-2,4-dienimidic acid

C16H19NO3 (273.1365)


   

(3e,5e)-6-(4-methoxyphenyl)-n-(2-methylpropyl)hexa-3,5-dienimidic acid

(3e,5e)-6-(4-methoxyphenyl)-n-(2-methylpropyl)hexa-3,5-dienimidic acid

C17H23NO2 (273.1729)


   

α-erythroidine

α-erythroidine

C16H19NO3 (273.1365)


   

(1s,15r,16s)-5-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraene-4,15-diol

(1s,15r,16s)-5-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraene-4,15-diol

C16H19NO3 (273.1365)


   

1-[(2r,6s)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methyl-5,6-dihydro-2h-pyridin-2-yl]propan-2-one

1-[(2r,6s)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methyl-5,6-dihydro-2h-pyridin-2-yl]propan-2-one

C17H23NO2 (273.1729)


   

3-[(1e)-3-hydroxy-3-methylbut-1-en-1-yl]-4-methoxy-1-methylquinolin-2-one

3-[(1e)-3-hydroxy-3-methylbut-1-en-1-yl]-4-methoxy-1-methylquinolin-2-one

C16H19NO3 (273.1365)


   

(+/-)-lunacrine

(+/-)-lunacrine

C16H19NO3 (273.1365)


   

2-hydroxy-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadeca-7,9-diene-11,12-dione

2-hydroxy-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadeca-7,9-diene-11,12-dione

C16H19NO3 (273.1365)


   

(2e,4e,6e)-1-(piperidin-1-yl)-7-(thiophen-2-yl)hepta-2,4,6-trien-1-one

(2e,4e,6e)-1-(piperidin-1-yl)-7-(thiophen-2-yl)hepta-2,4,6-trien-1-one

C16H19NOS (273.1187)


   

4-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-5,12-diol

4-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-5,12-diol

C16H19NO3 (273.1365)


   

(1s,14r)-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6(17),7,9,15-tetraene-9,14-diol

(1s,14r)-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6(17),7,9,15-tetraene-9,14-diol

C16H19NO3 (273.1365)


   

16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2,12,14-trien-4-one

16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2,12,14-trien-4-one

C16H19NO3 (273.1365)


   

4'-o-methylnorbelladine

4'-o-methylnorbelladine

C16H19NO3 (273.1365)


   

3-[(2e)-but-2-en-1-yl]-4-ethoxy-8-hydroxy-1-methylquinolin-2-one

3-[(2e)-but-2-en-1-yl]-4-ethoxy-8-hydroxy-1-methylquinolin-2-one

C16H19NO3 (273.1365)


   

(3e)-4-[4-methyl-2-(3-oxohexyl)phenyl]but-3-enimidic acid

(3e)-4-[4-methyl-2-(3-oxohexyl)phenyl]but-3-enimidic acid

C17H23NO2 (273.1729)


   

(1r,10s,12r)-4-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-5,12-diol

(1r,10s,12r)-4-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-5,12-diol

C16H19NO3 (273.1365)


   

(1s,15r,16s)-4-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraene-5,15-diol

(1s,15r,16s)-4-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraene-5,15-diol

C16H19NO3 (273.1365)


   

(1r,9s,10r,13s,14r,16s)-14-methyl-11-oxa-5-azapentacyclo[7.4.3.1¹⁰,¹³.0¹,¹⁶.0⁵,¹⁶]heptadec-3-ene-2,12-dione

(1r,9s,10r,13s,14r,16s)-14-methyl-11-oxa-5-azapentacyclo[7.4.3.1¹⁰,¹³.0¹,¹⁶.0⁵,¹⁶]heptadec-3-ene-2,12-dione

C16H19NO3 (273.1365)


   

2-(2-methoxypropan-2-yl)-9-methyl-2h,3h-furo[2,3-b]quinolin-4-one

2-(2-methoxypropan-2-yl)-9-methyl-2h,3h-furo[2,3-b]quinolin-4-one

C16H19NO3 (273.1365)


   

4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6(17),7,9,15-tetraene-9,14-diol

4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6(17),7,9,15-tetraene-9,14-diol

C16H19NO3 (273.1365)


   

n-[2-(2,2-dimethylchromen-6-yl)ethyl]-2-methylpropanimidic acid

n-[2-(2,2-dimethylchromen-6-yl)ethyl]-2-methylpropanimidic acid

C17H23NO2 (273.1729)


   

3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-4-methoxy-1-methylquinolin-2-one

3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-4-methoxy-1-methylquinolin-2-one

C16H19NO3 (273.1365)


   

(1s,3s,8s,9r,12s)-5,14-dimethyl-5-azatetracyclo[7.7.0.0¹,¹².0³,⁸]hexadec-14-ene-10,16-dione

(1s,3s,8s,9r,12s)-5,14-dimethyl-5-azatetracyclo[7.7.0.0¹,¹².0³,⁸]hexadec-14-ene-10,16-dione

C17H23NO2 (273.1729)


   

(1s,13s,15r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-trien-15-ol

(1s,13s,15r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-trien-15-ol

C16H19NO3 (273.1365)


   

5-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-4,12-diol

5-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-4,12-diol

C16H19NO3 (273.1365)


   

(1r,2r,3r,5s)-2-benzyl-8-methyl-8-azabicyclo[3.2.1]octan-3-yl acetate

(1r,2r,3r,5s)-2-benzyl-8-methyl-8-azabicyclo[3.2.1]octan-3-yl acetate

C17H23NO2 (273.1729)


   

(1r,13r,15s)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-trien-15-ol

(1r,13r,15s)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-trien-15-ol

C16H19NO3 (273.1365)


   

14-methyl-11-oxa-5-azapentacyclo[7.4.3.1¹⁰,¹³.0¹,¹⁶.0⁵,¹⁶]heptadec-3-ene-2,12-dione

14-methyl-11-oxa-5-azapentacyclo[7.4.3.1¹⁰,¹³.0¹,¹⁶.0⁵,¹⁶]heptadec-3-ene-2,12-dione

C16H19NO3 (273.1365)


   

4-[(1z)-2-{[(1s,5s)-5-methoxy-2-methylcyclohex-2-en-1-yl](methyl)amino}ethenyl]phenol

4-[(1z)-2-{[(1s,5s)-5-methoxy-2-methylcyclohex-2-en-1-yl](methyl)amino}ethenyl]phenol

C17H23NO2 (273.1729)


   

2-benzyl-8-methyl-8-azabicyclo[3.2.1]octan-3-yl acetate

2-benzyl-8-methyl-8-azabicyclo[3.2.1]octan-3-yl acetate

C17H23NO2 (273.1729)


   

β-erythroidine

β-erythroidine

C16H19NO3 (273.1365)


   

(1r,10s,12s)-5-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-4,12-diol

(1r,10s,12s)-5-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-4,12-diol

C16H19NO3 (273.1365)


   

1-(1h-indol-3-yl)-4-methyl-3-oxopentan-2-yl acetate

1-(1h-indol-3-yl)-4-methyl-3-oxopentan-2-yl acetate

C16H19NO3 (273.1365)


   

4-methoxy-1-methyl-8-[(3-methylbut-2-en-1-yl)oxy]quinolin-2-one

4-methoxy-1-methyl-8-[(3-methylbut-2-en-1-yl)oxy]quinolin-2-one

C16H19NO3 (273.1365)


   

4-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}butanoic acid

4-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}butanoic acid

C12H19NO6 (273.1212)


   

4-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraene-5,15-diol

4-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraene-5,15-diol

C16H19NO3 (273.1365)


   

5-(2h-1,3-benzodioxol-5-yl)-n-(sec-butyl)penta-2,4-dienamide

5-(2h-1,3-benzodioxol-5-yl)-n-(sec-butyl)penta-2,4-dienamide

C16H19NO3 (273.1365)


   

3-{[1-(acetyloxy)-3-methylpentan-2-yl]-c-hydroxycarbonimidoyl}-3-methylpropanoic acid

3-{[1-(acetyloxy)-3-methylpentan-2-yl]-c-hydroxycarbonimidoyl}-3-methylpropanoic acid

C13H23NO5 (273.1576)


   

4-[2-(dimethylamino)ethyl]-4-(4-methoxyphenyl)cyclohex-2-en-1-one

4-[2-(dimethylamino)ethyl]-4-(4-methoxyphenyl)cyclohex-2-en-1-one

C17H23NO2 (273.1729)


   

4-hydroxy-2-octylquinolin-1-ium-1-olate

4-hydroxy-2-octylquinolin-1-ium-1-olate

C17H23NO2 (273.1729)


   

4-[(2-amino-3-hydroxyphenyl)methylidene]-5-(hydroxymethylidene)-3-methylideneheptan-2-one

4-[(2-amino-3-hydroxyphenyl)methylidene]-5-(hydroxymethylidene)-3-methylideneheptan-2-one

C16H19NO3 (273.1365)


   

(4z,5e)-4-[(2-amino-3-hydroxyphenyl)methylidene]-5-(hydroxymethylidene)-3-methylideneheptan-2-one

(4z,5e)-4-[(2-amino-3-hydroxyphenyl)methylidene]-5-(hydroxymethylidene)-3-methylideneheptan-2-one

C16H19NO3 (273.1365)


   

(3s,6s)-3-(hydroxymethyl)-6-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

(3s,6s)-3-(hydroxymethyl)-6-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

C14H15N3O3 (273.1113)


   

(2e,4z)-5-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)penta-2,4-dienimidic acid

(2e,4z)-5-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)penta-2,4-dienimidic acid

C16H19NO3 (273.1365)


   

(1s,10r,12r)-4-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-5,12-diol

(1s,10r,12r)-4-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-5,12-diol

C16H19NO3 (273.1365)


   

(2e,4e)-5-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)penta-2,4-dienimidic acid

(2e,4e)-5-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)penta-2,4-dienimidic acid

C16H19NO3 (273.1365)


   

3-[(2s)-2-hydroxy-3-methylbut-3-en-1-yl]-4-methoxy-1-methylquinolin-2-one

3-[(2s)-2-hydroxy-3-methylbut-3-en-1-yl]-4-methoxy-1-methylquinolin-2-one

C16H19NO3 (273.1365)


   

(2e)-3-(2h-1,3-benzodioxol-5-yl)-1-(4-methylpiperidin-1-yl)prop-2-en-1-one

(2e)-3-(2h-1,3-benzodioxol-5-yl)-1-(4-methylpiperidin-1-yl)prop-2-en-1-one

C16H19NO3 (273.1365)


   

6-(4-methoxyphenyl)-n-(2-methylpropyl)hexa-3,5-dienimidic acid

6-(4-methoxyphenyl)-n-(2-methylpropyl)hexa-3,5-dienimidic acid

C17H23NO2 (273.1729)


   

(1s,2s,13r,15r)-2-hydroxy-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadeca-7,9-diene-11,12-dione

(1s,2s,13r,15r)-2-hydroxy-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadeca-7,9-diene-11,12-dione

C16H19NO3 (273.1365)


   

(4s)-4-[2-(dimethylamino)ethyl]-4-(4-methoxyphenyl)cyclohex-2-en-1-one

(4s)-4-[2-(dimethylamino)ethyl]-4-(4-methoxyphenyl)cyclohex-2-en-1-one

C17H23NO2 (273.1729)


   

4,8-dimethoxy-3-(3-methylbut-2-en-1-yl)quinolin-2-ol

4,8-dimethoxy-3-(3-methylbut-2-en-1-yl)quinolin-2-ol

C16H19NO3 (273.1365)


   

3-(3-hydroxy-3-methylbut-1-en-1-yl)-4-methoxy-1-methylquinolin-2-one

3-(3-hydroxy-3-methylbut-1-en-1-yl)-4-methoxy-1-methylquinolin-2-one

C16H19NO3 (273.1365)


   

(1s,2r,4r,8s,9r,11s)-8-[(1e,3e,5e)-5-methylhepta-1,3,5-trien-1-yl]-3-oxa-7-azatetracyclo[5.4.0.0²,⁴.0⁹,¹¹]undecan-1-ol

(1s,2r,4r,8s,9r,11s)-8-[(1e,3e,5e)-5-methylhepta-1,3,5-trien-1-yl]-3-oxa-7-azatetracyclo[5.4.0.0²,⁴.0⁹,¹¹]undecan-1-ol

C17H23NO2 (273.1729)


   

(2r)-1-(1h-indol-3-yl)-4-methyl-3-oxopentan-2-yl acetate

(2r)-1-(1h-indol-3-yl)-4-methyl-3-oxopentan-2-yl acetate

C16H19NO3 (273.1365)


   

(1s,12s,14s)-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-ol

(1s,12s,14s)-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-ol

C16H19NO3 (273.1365)


   

8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-phenylpropanoate

8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-phenylpropanoate

C17H23NO2 (273.1729)


   

5-{[2-(4-hydroxyphenyl)ethyl](methyl)amino}-2-methoxyphenol

5-{[2-(4-hydroxyphenyl)ethyl](methyl)amino}-2-methoxyphenol

C16H19NO3 (273.1365)


   

n-[2-(2,2-dimethylchromen-6-yl)ethyl]butanimidic acid

n-[2-(2,2-dimethylchromen-6-yl)ethyl]butanimidic acid

C17H23NO2 (273.1729)


   

(2e,4e)-5-(2h-1,3-benzodioxol-5-yl)-n-[(2s)-butan-2-yl]penta-2,4-dienimidic acid

(2e,4e)-5-(2h-1,3-benzodioxol-5-yl)-n-[(2s)-butan-2-yl]penta-2,4-dienimidic acid

C16H19NO3 (273.1365)


   

6-(4-methoxyphenyl)-n-(2-methylpropyl)hexa-2,4-dienimidic acid

6-(4-methoxyphenyl)-n-(2-methylpropyl)hexa-2,4-dienimidic acid

C17H23NO2 (273.1729)


   

(2e,8e)-7-hydroxy-n-(2-methylpropyl)trideca-2,8-dien-10,12-diynimidic acid

(2e,8e)-7-hydroxy-n-(2-methylpropyl)trideca-2,8-dien-10,12-diynimidic acid

C17H23NO2 (273.1729)


   

5-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)penta-2,4-dienamide

5-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)penta-2,4-dienamide

C16H19NO3 (273.1365)


   

(1s,7r,16r)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2,12,14-trien-4-one

(1s,7r,16r)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2,12,14-trien-4-one

C16H19NO3 (273.1365)


   

2-hexyl-8-methoxy-1-methylquinolin-4-one

2-hexyl-8-methoxy-1-methylquinolin-4-one

C17H23NO2 (273.1729)


   

3-(2-hydroxy-3-methylbut-3-en-1-yl)-4-methoxy-1-methylquinolin-2-one

3-(2-hydroxy-3-methylbut-3-en-1-yl)-4-methoxy-1-methylquinolin-2-one

C16H19NO3 (273.1365)


   

1-[6-(2-hydroxy-2-phenylethyl)-1-methyl-5,6-dihydro-2h-pyridin-2-yl]propan-2-one

1-[6-(2-hydroxy-2-phenylethyl)-1-methyl-5,6-dihydro-2h-pyridin-2-yl]propan-2-one

C17H23NO2 (273.1729)


   

(2e)-3-(2h-1,3-benzodioxol-5-yl)-n-cyclohexylprop-2-enimidic acid

(2e)-3-(2h-1,3-benzodioxol-5-yl)-n-cyclohexylprop-2-enimidic acid

C16H19NO3 (273.1365)